Related Experiment Video
Updated: Jun 16, 2026
08:24
Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
[Inflammatory bowel diseases and enteric microbiota].
1Department of Microbiology, Hanyang University College of Medicine, Seoul, Korea. jungmogg@hanyang.ac.kr
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi
|January 26, 2010
Summary
The gut microbiota influences inflammatory bowel disease (IBD) development. Dysbiosis, an imbalance in gut microbes, is linked to immune defects and IBD pathogenesis, suggesting microbial targets for therapy.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Context:
- The intestinal microbiota plays a dual role, offering benefits in health but contributing to chronic inflammatory diseases like inflammatory bowel disease (IBD) in susceptible individuals.
- The gut microbiome's influence on the host immune system is critical, impacting immune homeostasis and disease development.
- Dysbiosis, an altered microbial composition, is increasingly recognized as a key factor in IBD pathogenesis.
Purpose:
- To review the significant impact of enteric microbiota on the development and perpetuation of inflammatory bowel disease (IBD).
- To explore the intricate interactions between intestinal bacteria and host mucosal cells (epithelial cells, dendritic cells, T cells) in driving immune responses relevant to IBD.
- To highlight the potential of understanding enteric microbiota for novel therapeutic strategies against IBD.
Summary:
- Intestinal microbes are crucial in IBD pathogenesis, with dysbiosis associated with immune dysfunction.
- The review details how enteric bacteria interact with mucosal cells, influencing immune responses at the gut surface.
- Specific defects in immune functions like microbe recognition and barrier integrity are linked to dysbiosis in IBD.
Impact:
- Advances in understanding the enteric microbiota offer potential for developing new therapeutic strategies for IBD.
- This knowledge can elucidate the complex etiology of IBD, moving beyond the unknown.
- Targeting microbial imbalances may provide novel treatment avenues for patients suffering from inflammatory bowel disease.
Related Concept Videos
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...